Stereospecificity of the in vitro and in vivo blockade of beta-receptors by FM 24, a slowly reversible ligand.
D000319:Adrenergic beta-Antagonists; D000818:Animals; D001592:Benzyl Alcohols; D001667:Binding, Competitive / Q000187:drug effects; D002540:Cerebral Cortex / Q000378:metabolism; D004082:Dihydroalprenolol; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008566:Membranes / Q000378:metabolism; D010869:Pindolol / Q000031:analogs & derivatives; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013237:Stereoisomerism
D000319:Adrenergic beta-Antagonists; D001592:Benzyl Alcohols; D011412:Propanolamines; D004082:Dihydroalprenolol; C018417:bornaprolol; C012357:hydroxybenzylpindolol; D011433:Propranolol; D010869:Pindolol